Morning Session: Pharmacogenetics Testing

Pharmacogenetics of Psychosis  (Antipsychotics and Mood Stabilizers)

Daniel Mueller, M.D., Ph.D.

University of Toronto

Moderator/Chair

Pharmacogenetic Informed Prescribing for Major Depressive Disorder

Chad Bousman, PhD

University of Calgary

Pharmacogenomic Testing Improves Remission Rates in Patients with Depression: A Meta-Analysis and Lived Experience

Lisa Brown, Ph.D.

Great Scott! Consulting

How Participating in CAMH's Pharmacogenetics Impact Study Changed My Life

Larry Meikle

Pharmacogenetics of Anxiety and Obsessive-Compulsive Disorders

Gwyneth Zai, M.D., Ph.D.

Centre for Addiction and Mental Health, University of Toronto

Issues in Implementation and Cost-Benefit of Pharmacogenetic Testing for Depression

Jim Kennedy, FRCP(C), M.D.

Centre for Addiction and Mental Health, University of Toronto

Afternoon Session: Underlying Genetic Conditions and Managing Genetic Risk

Genetic counseling for psychiatric disorders

Jehannine Austin, Ph.D.

University of British Columbia

Practical applications of medical genetics and genomics for psychiatrists

Yannis Trakadis, M.D.

McGill University

Rare or Rarely Diagnosed? Treatable Genetic Syndromes in Adult Neuropsychiatric Patients

Joyce So, M.D., Ph.D.

University of California, San Francisco

Education Day Chair

Gustavo Turecki, M.D., Ph.D.

McGill University